Health Disparity Clusters of Off Label Prescriptions for Glucagon-Like Peptide 1 Receptor Agonists
We identified distinct populations with varying GLP-1 RA off-label prescribing and known health disparities. These results could inform clinical and market strategies to increase access to GLP-1 RAs in underserved populations.
Authors
- Mary T. Imboden (ORCID: https://orcid.org/0000-0003-4088-814X)
- Austin B. Miller (ORCID: https://orcid.org/0000-0001-5508-3147)
- Kateri J. Spinelli (ORCID: https://orcid.org/0000-0002-6290-0886)
- Sanjula Jain
- Ty J. Gluckman (ORCID: https://orcid.org/0000-0002-7187-6822)
- Allison H. Oakes (ORCID: https://orcid.org/0000-0003-1516-0034)
- Shih‐Ting Chiu
Institutions
- Johns Hopkins University (US)
- Johns Hopkins Medicine (US)
- Brentwood Hospital (US)
- Providence Center (US)
Publication Details
- Journal
- American Journal of Medicine Open
- Published
- 2025-04-06
- DOI
- https://doi.org/10.1016/j.ajmo.2025.100100
- Citations
- 7
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 9.06